For the Inventor, By the Inventor

Enter assignee name

Stamford, CT, United States of America

Loxo Oncology, Inc.

USPTO Granted Patents = 34

CIPO Patents = 2

EPO Patents = 9

Trademarks = 1

Forward Citations = 62

Loading Chart...

Loading Chart...

32 inventors (with patents filed for the assignee):

Charles Todd Eary (11 out of 17 patents)

Nicolas Guisot (11 out of 11 patents)

Nisha Nanda (8 out of 8 patents)

4. Gabrielle R Kolakowski (8 out of 58 patents)

5. Mark A Reynolds (8 out of 29 patents)

6. Stacey Spencer (7 out of 10 patents)

7. Barbara J Brandhuber (7 out of 31 patents)

8. Steven Wade Andrews (6 out of 97 patents)

9. James F Blake (5 out of 112 patents)

10. Joshua H Bilenker (5 out of 5 patents)

11. Adam Wade Cook (3 out of 41 patents)

12. Tony P Tang (3 out of 40 patents)

13. Andrew T Metcalf (3 out of 29 patents)

14. Michael Cox (3 out of 3 patents)

15. David A Moreno (3 out of 39 patents)

34 patents: Sort by Forward Citations

1. 12268666 - Spray-dried dispersions, formulations, and polymorphs of (S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide (2025-04-08),

2. 12220401 - Compounds useful as kinase inhibitors (2025-02-11),

3. 12138250 - Formulations of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile (2024-11-12),

4. 12109193 - Spray-dried dispersions, formulations, and polymorphs of (s)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide (2024-10-08),

5. 12102621 - Formulations of 6-(2-hydroxy-methylpropoxy-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile (2024-10-01),

6. 11963950 - Formulations of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile (2024-04-23),

7. 11826351 - Compounds useful as kinase inhibitors (2023-11-28),

8. 11807651 - Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile (2023-11-07),

9. 11484535 - Liquid formulations of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a] pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide (2022-11-01),

10. 11471441 - Compounds useful as kinase inhibitors (2022-10-18),

11. 11214571 - Process for the preparation of (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide and salts thereof (2022-01-04),

12. 11191766 - Methods of treating pediatric cancers (2021-12-07),

13. 11098064 - Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbontrile (2021-08-24),

14. 11091486 - Process for the preparation of pyrazolo[1,5-a]pyrimidines and salts thereof (2021-08-17),

15. 10918622 - Compounds useful as kinase inhibitors (2021-02-16),

Loxo Oncology, Inc. is a biopharmaceutical company that develops targeted therapies for the treatment of cancer. The company is focused on creating medicines that can address genetic mutations driving cancer growth across different tumor types. Loxo Oncology aims to revolutionize cancer treatment through precision medicine and personalized therapies.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

34 Patents

#22 in Stamford, CT

#227 in Connecticut

#9,678 in US

#19,059 in the World

Stamford, CT, United States of America

Loxo Oncology, Inc.

Forward Citations = 62

32 inventors:

Charles Todd Eary (11 out of 17 patents)

Nicolas Guisot (11 out of 11 patents)

Nisha Nanda (8 out of 8 patents)

4. Gabrielle R Kolakowski (8 out of 58 patents)

5. Mark A Reynolds (8 out of 29 patents)

Please report any incorrect information to support@idiyas.com

Loading…